Search

everythinglearnresearchcommunity

for

Search:↓

The activity of a specific rat enzyme in the prostate and epididymis is highly dependent on the acidity level.

Finasteride increases CD8+ T cells in BPH tissues.

5α reductase type 2 enzyme mutation and oxidative stress may increase androgenetic alopecia risk in Egyptians.

New compounds called benzoquinolinones may treat conditions linked to excess DHT.

5α-Reductase inhibitors can help treat hair loss, acne, and prostate issues by reducing DHT levels.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

Male pattern baldness is caused by certain cells in hair follicles and could potentially be treated by targeting a specific growth factor, TGF-β1.

Anti-aging treatments like hair transplants, minoxidil, and finasteride effectively promote hair growth.

Dutasteride reduces DHT and improves BPH symptoms more effectively than finasteride.

People with hair loss have more androgen receptors and enzymes in certain follicles, with men and women showing different patterns.

The human type II 5α-reductase gene, linked to certain male health conditions, has a specific structure and low similarity to other related genes.

The human type II 5α-reductase gene has a specific structure important for understanding certain medical conditions.

Dutasteride is more efficient than finasteride, but individual results vary.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

Testosterone and dihydrotestosterone treatments can help with penile growth in males with 5α-reductase type 2 deficiency, with dihydrotestosterone being more effective in infancy.

Finasteride doesn't harm bone density in older men with BPH.

Low dose finasteride decreases certain steroids, possibly increasing depression risk.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Finasteride effectively treats male pattern hair loss with a 1 mg daily dose.

New steroid compounds effectively inhibit 5α-reductase and may treat hair loss.

New compounds were made that effectively block a specific enzyme related to androgen conditions.

New compounds show promise as nonsteroidal treatments for hair loss.

New drug dutasteride effectively treats hair loss, but use cautiously due to potential sexual side effects.

Hair sensitivity to androgens is partly controlled by specific enzyme expressions in different hair areas.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

Blocking the enzyme 5α-reductase can shrink the prostate and help treat enlarged prostate issues.

Some newly made compounds can block an enzyme linked to hair loss and prostate growth, with one in particular being very selective.

The document concludes that various cosmetic and drug treatments are available for hirsutism, and some new drugs show promise.

Scientists made a carbon-14 labeled version of a drug with a 48% yield and over 99% purity.

Chitrak is a medicinal plant with health benefits like fighting microbes, reducing inflammation, and promoting hair growth, but it can be toxic and needs more research.